Goldman Sachs quarterly bond trading revenue drops 26 percent
October 17, 2017Wall St flat as losses in financials offset healthcare gains
October 17, 2017Strong drug sales, Actelion buy power J&J’s profit beat
at
(Reuters) – Johnson & Johnson reported a higher-than-expected quarterly profit and raised its full-year forecast, driven by strong demand for its new cancer drugs and gains from its acquisition of Swiss biotech Actelion.
Powered by WPeMatico
